Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2D326F6770
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $17,066
Award facts
- Contract value 100% obligated
- $17,065.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain issued a delivery order to Chartwell RX LLC on February 27, 2026, with a ceiling value of $17,065.50 for ondansetron ODT 8 mg tablets (30-count packages). Ultimate completion is March 2, 2026. Place of performance is Congers, NY. The order is priced firm fixed-price with no set-aside applied.
Quick answers
Who was awarded contract SPE2D326F6770?
SPE2D326F6770 was awarded to Chartwell RX LLC by Medical Supply Chain (Troop Support) on February 27, 2026.
How much is contract SPE2D326F6770 worth?
The government has obligated $17,066 on SPE2D326F6770.
Is contract SPE2D326F6770 an order under another contract?
Yes. SPE2D326F6770 is a delivery order under SPE2D020D0005, an indefinite delivery contract.
Was contract SPE2D326F6770 competed?
The extent of competition for SPE2D326F6770 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award